Literature DB >> 27797902

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2.

Charles A Herzog1.   

Abstract

Entities:  

Keywords:  Anticoagulants; Atrial fibrillation; Blood Coagulation; Disease Management; Humans; Kidney Failure, Chronic; end-stage renal disease

Mesh：

Substances：

Year:  2016        PMID： 27797902      PMCID： PMC5108205          DOI： 10.2215/CJN.09470916

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  6 in total

1.  K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients.

Authors: 
Journal:  Am J Kidney Dis       Date:  2005-04       Impact factor: 8.860

2.  Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  Charles A Herzog; Richard W Asinger; Alan K Berger; David M Charytan; Javier Díez; Robert G Hart; Kai-Uwe Eckardt; Bertram L Kasiske; Peter A McCullough; Rod S Passman; Stephanie S DeLoach; Patrick H Pun; Eberhard Ritz
Journal:  Kidney Int       Date:  2011-07-13       Impact factor: 10.612

Review 3.  Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.

Authors:  Arman Qamar; Deepak L Bhatt
Journal:  Circulation       Date:  2016-04-12       Impact factor: 29.690

4.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Pro.

Authors:  Peter A McCullough; Timothy Ball; Katy Mathews Cox; Manish D Assar
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

Review 5.  Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.

Authors:  Vaibhav Keskar; Manish M Sood
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-25       Impact factor: 8.237

Review 6.  Anticoagulants in atrial fibrillation patients with chronic kidney disease.

Authors:  Robert G Hart; John W Eikelboom; Alistair J Ingram; Charles A Herzog
Journal:  Nat Rev Nephrol       Date:  2012-07-24       Impact factor: 28.314
  6 in total
  2 in total

1.  Relation of Race, Apparent Disability, and Stroke Risk With Warfarin Prescribing for Atrial Fibrillation in Patients Receiving Maintenance Hemodialysis.

Authors:  James B Wetmore; Yi Peng; David T Gilbertson; Jiannong Liu
Journal:  Am J Cardiol       Date:  2018-11-24       Impact factor: 2.778

2.  Design and rationale of a randomised controlled trial comparing apixaban to phenprocoumon in patients with atrial fibrillation on chronic haemodialysis: the AXADIA-AFNET 8 study.

Authors:  Holger Reinecke; Sabine Jürgensmeyer; Christiane Engelbertz; Joachim Gerss; Paulus Kirchhof; Günter Breithardt; Rupert Bauersachs; Christoph Wanner
Journal:  BMJ Open       Date:  2018-09-10       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.